Leucocyte labelling with 99mTc-exametazime and polycythemia vera: a casual finding
DOI:
https://doi.org/10.30827/ars.v60i4.9410Keywords:
polycythemia vera, labelled leukocytes, erythrocyte sedimentation rateAbstract
The official World Health Organization classification of hematopoietic and lymphoid tissue tumors introduces in 2016 the concept of masked polycythemia vera (PV) and reveals that this entity has been underdiagnosed in the past. We present the case of a 49-year-old man, smoker, operated on for ankle fracture more than 15 years ago, referred to evaluate a possible associated infectious process. As there was no previous separation of the red blood cells by sedimentation during the leukocyte labelling procedure with 99mTc-exametazima, the causes of decreased erythrocyte sedimentation rate were reviewed. These include polyglobulia and smoking, both present in the patient. A haematological study was advised, which concluded with the diagnosis of PV. The indications of the specialist in Radiopharmacy allowed diagnosing a case not identified until then, although the patient had had symptoms for years.
Downloads
References
McMullin MF, Wilkins BS, Harrison CN. Management of polycythaemia vera: a critical review of current data. British Journal of Haematology. 2016;172(3):337-49. doi: 10.1111/bjh.13812.
Stein BL, Moliterno AR, Tiu RV. Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options. Ann Hematol. 2014;93(12):1965-76. doi: 10.1007/s00277-014-2205-y.
Barbui T, Thiele J, Gisslinger H, et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer Journal. 2018;8(2):15. doi: 10.1038/s41408-018-0054-y.
Sultan S, Irfan SM, Murad S. Clinico-Epidemiological Profile of Patients with Polycythaemia Rubra Vera - a Five Year Experience from a Tertiary Care Center. Asian Pac J Cancer Prev. 2016;17(3):1531- 3. doi: 10.7314/apjcp.2016.17.3.1531.
Palestro CJ. Radionuclide Imaging of Musculoskeletal Infection: A Review. J Nucl Med. 2016;57(9):1406-12. doi: 10.2967/jnumed.115.157297.
Palestro CJ, Love C, Miller TT. Imaging of musculoskeletal infections. Best Practice & Research Clinical Rheumatology. 2006;20(6):1197-218. doi: 10.1016/j.berh.2006.08.009.
Love C, Patel M, Lonner BS, Tomas MB, Palestro CJ. Diagnosing spinal osteomyelitis: a comparison of bone and Ga-67 scintigraphy and magnetic resonance imaging. Clin Nucl Med. 2000;25(12):963-77. doi: 10.1097/00003072-200012000-00002 ·
Agencia Española de Medicamentos y Productos Sanitarios - Medicamentos de Uso Humano - Fabricación de Medicamentos - Farmacopea - Marcaje de Leucocitos con Tecnecio (99mTc) Exametazima (HM-PAO). [citado 14 de mayo de 2019]. Disponible en: https://www.aemps.gob.es/medicamentosUsoHumano/farmacopea/informacionRFE/guia1.htm.
Pérez FJ, Matilla A, Tercero JM, Martínez F, Becerra D. Red blood cells labelling with 99mTc-d, l-HMPAO: an alternative method for specific cases. J Label Compd Radiopharm. 2003;46(10):945-58. doi: 10.1002/jlcr.728.
Merino Romero J. Utilidad diagnóstica de la velocidad de sedimentación globular. Med Integr. 2002;39(7):325-9.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Mónica Romero Otero, Mar Soria-Merino, Roberto Maestre-Cutillas, Rafael Díaz-Expósito, Héctor Rodríguez-Parra, Adela Cánoves-Llombart, Jorge Sabater-Sancho, Viviana Carrero-Vásquez
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
